Contact
Please use this form to send email to PR contact of this press release:
FibroGen Announces Topline Results from Two Late-Stage Pamrevlumab Pancreatic Cancer Studies and Provides Corporate Update
TO:
Please use this form to send email to PR contact of this press release:
FibroGen Announces Topline Results from Two Late-Stage Pamrevlumab Pancreatic Cancer Studies and Provides Corporate Update
TO: